%0 Journal Article
%T Biocompatibility of crystalline opal nanoparticles
%A Hern¨˘ndez-Ortiz Marlen
%A Acosta-Torres Laura S
%A Hern¨˘ndez-Padr¨®n Genoveva
%A Mendieta Alicia I
%J BioMedical Engineering OnLine
%D 2012
%I BioMed Central
%R 10.1186/1475-925x-11-78
%X Background Silica nanoparticles are being developed as a host of biomedical and biotechnological applications. For this reason, there are more studies about biocompatibility of silica with amorphous and crystalline structure. Except hydrated silica (opal), despite is presents directly and indirectly in humans. Two sizes of crystalline opal nanoparticles were investigated in this work under criteria of toxicology. Methods In particular, cytotoxic and genotoxic effects caused by opal nanoparticles (80 and 120 nm) were evaluated in cultured mouse cells via a set of bioassays, methylthiazolyldiphenyl-tetrazolium-bromide (MTT) and 5-bromo-2ˇä-deoxyuridine (BrdU). Results 3T3-NIH cells were incubated for 24 and 72 h in contact with nanocrystalline opal particles, not presented significant statistically difference in the results of cytotoxicity. Genotoxicity tests of crystalline opal nanoparticles were performed by the BrdU assay on the same cultured cells for 24 h incubation. The reduction of BrdU-incorporated cells indicates that nanocrystalline opal exposure did not caused unrepairable damage DNA. Conclusions There is no relationship between that particles size and MTT reduction, as well as BrdU incorporation, such that the opal particles did not induce cytotoxic effect and genotoxicity in cultured mouse cells.
%K Cytotoxicity
%K Genototoxicity
%K Synthetic opal
%K BrdU and MTT assay
%U http://www.biomedical-engineering-online.com/content/11/1/78